According to a study ,Gray matter volume is associated with walking outcomes, including speed, stride duration variability.The double support time in individuals with diabetes with a stronger affiliation seen for those with diabetic peripheral neuropathy (DPN).
Studies clinically evaluated important walking outcomes, including speed, stride duration variability, and double support time.
The researchers found that, compared with those with DM and control participants, individuals with DPN walked significantly more slowly, with significantly greater stride duration variability and longer double support.
People with DPN who had lower global and regional (cerebellum, right-hemisphere dorsolateral prefrontal cortex, and basal ganglia) gray matter volume walked more slowly, with greater stride duration variability and/or longer double support. Each of these associations was more robust in individuals with DPN than those with DM. Brain volumes did not relate to walking patterns .